On Jul 1, 2021 OBVIOHEALTH closed a Series B round and raised $31,000,000 from AT Capital Group, Dedalus Group, Novotech, SPRIM, featuring lead investors Dedalus […]
On Jul 1, 2021 OBVIOHEALTH closed a Series B round and raised $31,000,000 from AT Capital Group, Dedalus Group, Novotech, SPRIM, featuring lead investors Dedalus […]